« Back to Record
Citation APA

Hamilton, A., Biganzoli, L., Coleman, R., Mauriac, L., Hennebert, P., Awada, A., Nooij, M., Beex, L., Piccart-Gebhart, M., Van Hoorebeeck, I., Bruning, P., & de Valeriola, D. (2002). EORTC 10968: A phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer. Annals of oncology, 13(6), 910-918. doi:10.1093/annonc/mdf157


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/84202

Hamilton, A., Biganzoli, L., Coleman, R., Mauriac, L., Hennebert, P., Awada, A., Nooij, M., Beex, L., Piccart-Gebhart, M., Van Hoorebeeck, I., Bruning, P., & de Valeriola, D. (2002). EORTC 10968: A phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer. Annals of oncology, 13(6), 910-918. doi:10.1093/annonc/mdf157